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The recent introduction of the new long-acting insulin zinc suspension (IZS) by Hallas-M0ller (Hallas-M0ller, Jersild, Petersen and Schlichtkrull, 1952) at the Novo Laboratories, Denmark, raised the two questions of whether this preparation could be used with success in children, and whether it offered advantages over the other long-acting insulins. The amorphous form of IZS (Novo 'semilente') is said to act for 12 to 16 hours after injection, and the crystalline form (Novo 'ultralente') for more than 24 hours. Novo 'lente' is a stable mixture containing 30% amorphous and 70% crystalline IZS. Reports on the use of IZS in adult diabetics have so far tended to be mainly favourable (FitzGerald, Thorn and Malins, 1954; Hallas-M0ller et al., 1952; Lawrence and Oakley, 1953; Murray and Wilson, 1953; Nabarro and Stowers, 1953; Venning, 1954) . Lawrence (1954) states that children have responded well. When IZS (Novo) became available to us in August, 1953, we decided to conduct a trial in diabetic children. The first aim was to assess its practical value by clinical standards, regarding satisfactory clinical control as the most important criterion, and blood sugar studies primarily as an aid to achieving this. The standards for satisfactory clinical control were that the children should, while leading unrestricted lives, feel well and be free of all symptoms, with an upward weight trend. At the same time the urine should remain free of acetone, and a daily urinary sugar loss of not more than 10% of the d .ly carbohydrate intake was considered desirable. In this paper classification of clinical control has been restricted to two categories. Wherever control fell below the 'satisfactory' standard (as defined above), it has been classed as 'poor'. A secondary aim of the study was to compare, by simple clinical and biochemical criteria, the control obtainable respectively with two daily injections of soluble insulin and one of insulin zinc suspension. 
ARCHIVES OF DISEASE IN CHILDHOOD
and range. During one period she developed acetonuria and heavy glycosuria, probably as a result of injecting her insulin into sites of marked local induration. During the month after her discharge home on October 23 the dose of Novo 'lente' had to be progressively dropped from 50 to 40 units to avoid mild symptoms of hypoglycaemia in the late aftemoon. On the latter dose she has remained very well stabilized for five months. In a small proportion of the children, those with the highest insulin requirements, the pattern of the blood sugar variation was inconstant, and these children proved the most difficult to stabilize. It would doubtless have been possible to alter the blood sugar patterns by variations in the dietary distribution of carbohydrate, but in these studies diets were kept constant to facilitate the comparison of insulin action.
Of the 14 children discharged from hospital on IZS, nine were on Novo 'lente' alone. In Fig. 1 In three of the children, although 'lente' insulin gave good blood sugar control from 8 a.m. to 8 p.m., rather high midnight levels occurred. The addition of a proportion of the pure crystalline suspension ('ultralente') gave more prolonged control (Fig. 2) . In the light of this experience it is possible that some of our earlier cases, stabilized on 'lente' alone, might have benefited from the addition or substitution of a proportion of 'ultralente'. Two of our cases were stabilized on a mixture of 'lente' and 'semilente'. In one of these 'lente' alone had repeatedly failed to prevent a rather steeply rising blood sugar level throughout the day (Fig. 2) .
We have found, as similarly reported by others, a tendency for our cases on IZS to require a slightly higher dosage of insulin than previously (FitzGerald et al., 1954; Venning, 1954) . Of nine patients who were well stabilized before transfer to IZS, six required an increase in total units for good control with IZS. The average increase was 15 %. In two cases the total was unchanged, and in one it was slightly less (Table 3) .
Clinical Control. It has been possible to achieve satisfactory control with one injection of IZS in the majority of our cases, and so far to maintain good stabilization with the children leading normal lives at home. In four of the children adjustments have been made in insulin dosage or diet since they left hospital. Such adjustments must always be necessary in diabetic children if really good control is to be maintained, and will be needed with any insulin preparation. SI=soluble insulin. PZI=protamine-zinc insulin.
It is noteworthy that those three children in whom we failed to maintain satisfactory control with IZS had all previously proved particularly difficult and unstable cases. Further, we cannot yet say finally whether these children are better controlled by the older insulin preparations than by IZS.
Our experience so far with insulin-zinc suspension has given us the general impression that its action is reliable and smooth. We have experienced no alarming episodes during transfer from other insulins to IZS. Hypoglycaemic symptoms, if they occurred, tended to be regular and predictable with a gradual onset. With the Novo 'lente' mixture, hypoglycaemic symptoms were commonest between 10 a.m. and 6 p.m., and in only one case did they occur in the early hours of the morning.
In children with severe ketosis and vomiting, and where there is a threat of diabetic coma, we have used frequent injections of soluble insulin, and we believe that soluble insulin must retain its place in the treatment of such crises.
Practical Considerations. There has been no evidence of loss of potency in IZS (Novo) while we have been using it. Under the low power of the microscope the cuboidal insulin-zinc crystals contained in 'lente' and 'ultralente' are easily seen. The number of crystals per cubic millimetre in two vials of 'lente' were estimated, using a red cell counting chamber. The crystal counts in the new vials and in the same vials when nearly empty after use in the ward showed no significant variation.
We have found it important in practice to think of the three preparations 'semilente', 'lente' and 'ultralente', in terms of the two basic components, viz. amorphous (shorter-acting) and crystalline (longer-acting) insulin zinc suspensions. Failure to do this resulted in our administering to one case a larger proportion of the amorphous form than was intended when adding 'semilente' to 'lente'. The 442 ARCHIVES OF DISEASE IN CHILDHOOD graph recently published by Thorn (1954) has proved useful in this respect.
In none of our cases so far has a local inflammatory reaction occurred at the site of injection of IZS. The importance of varying the injection sites each day to ensure regular absorption was impressed on us by our experience with one case. While in hospital this child developed ketonuria for no apparent reason, until it was discovered that she was injecting all her 'lente' insulin into one of two indurated sites on her thighs. As soon as injections were given elsewhere, control was restored. It needs to be borne in mind that if insulin is given once daily smooth absorption is even more essential to the maintenance of control than it is when injections are more frequent.
Conclusions
From this short experience with a small number of cases it would be unjustifiable to draw anything but tentative conclusions. Nevertheless our findings have been encouraging enough for us to consider that insulin zinc suspension is likely to prove a reliable and effective long-acting insulin preparation. It appears probable that, by its use, reliable control could be maintained with a single daily injection in the majority of diabetic children. Summary A study has been made of insulin zinc suspension (IZS) in 15 diabetic children.
In 14 of the 15 children it proved possible to obtain satisfactory control in hospital with one daily injection of IZS. Fourteen of the children have been observed as out-patients, and 12 of them have remained well stabilized, though changes in the dosage have been needed in four of them.
In three of the children maintenance of control with IZS was poor, in one child while in hospital, and in two after returning home. All three had previously proved particularly unstable.
Four of the children were previously untreated and all of these were eventually well controlled by IZS. Two of them were treated initially with IZS and responded well.
In nine children blood sugar control with soluble insulin and with IZS was studied for comparison. The control obtainable with one daily injection of IZS was in all of them at least equal to that given by two injections of soluble insulin.
There has been no evidence of deterioration in the activity of IZS during the study, and no evident reactions have occurred at the sites of its injection.
It is suggested that the majority of diebetic children could probably be satisfactorily controlled by a single daily injection of insulin zinc suspension. 
